NEPH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $162,760.00

Insider Selling (Last 12 Months): $0.00

Nephros Insider Trading History Chart

Nephros Share Price & Price History

^$1.51

▲ +0.01 (0.67%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Financial Prophecy

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Nephros Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/30/2024	Arthur H Amron	Director	Buy	3,000	$2.24	$6,720.00	103,463
5/28/2024	Arthur H Amron	Director	Buy	2,000	$2.22	$4,440.00	100,463
5/16/2024	Robert R Jr. Banks	CEO	Buy	50,000	$2.24	$112,000.00	70,000
12/7/2023	Robert R Jr. Banks	CEO	Buy	18,000	$2.20	$39,600.00	20,000
8/14/2023	Robert R Jr. Banks	CEO	Buy	99	$1.50	$148.50	99

Financial Prophecy

From Porter & Company | Ad

Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Nephros (NASDAQ:NEPH)

41.10% of Nephros stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nephros Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/9/2024	Dimensional Fund Advisors LP	17,631	$37K	0.0%	N/A	0.167%
4/26/2024	Mesirow Financial Investment Management Inc.	15,383	$34K	0.0%	N/A	0.146%
2/10/2023	Bard Associates Inc.	194,789	$0.23M	0.1%	-22.7%	1.887%
11/15/2022	Elkhorn Partners Limited Partnership	50,341	$46K	0.0%	+48.1%	0.488%
8/11/2022	Bard Associates Inc.	263,754	$0.40M	0.2%	+7.0%	2.556%
8/1/2022	Cowen Prime Advisors LLC	42,500	$65K	0.0%	-47.1%	0.412%
5/23/2022	Cantor Fitzgerald L. P.	12,813	$56K	0.0%	N/A	0.124%
5/11/2022	Bard Associates Inc.	246,408	$1.08M	0.4%	+6.0%	2.388%
5/10/2022	Elkhorn Partners Limited Partnership	23,712	$0.10M	0.1%	+56.0%	0.230%
5/2/2022	Cowen Prime Advisors LLC	80,400	$0.35M	0.1%	-87.3%	0.780%
2/19/2022	Wexford Capital LP	3,650,529	$646.53M	27.0%	N/A	35.674%
2/14/2022	Elkhorn Partners Limited Partnership	15,200	$90K	0.1%	+78.8%	0.149%
2/8/2022	Cowen Prime Advisors LLC	633,050	$3.74M	1.3%	-4.1%	6.186%
2/8/2022	Samjo Capital LLC	425,000	$2.51M	1.7%	-22.7%	4.153%
11/9/2021	BlackRock Inc.	18,079	$0.16M	0.0%	-23.0%	0.177%
11/2/2021	Cowen Prime Advisors LLC	660,150	$5.79M	2.2%	+5.4%	6.461%
8/17/2021	Wexford Capital LP	3,631,197	$36.85M	5.6%	+1.9%	35.541%
8/13/2021	Vanguard Group Inc.	99,936	$1.01M	0.0%	+3.9%	0.978%
8/12/2021	Bard Associates Inc.	231,508	$2.35M	0.8%	+5.5%	2.266%
8/4/2021	Cowen Prime Advisors LLC	626,450	$6.36M	2.3%	N/A	6.290%
8/2/2021	Advisor Group Holdings Inc.	4,574	$46K	0.0%	+91,380.0%	0.046%
5/21/2021	Citadel Advisors LLC	18,421	$0.12M	0.0%	N/A	0.185%
5/18/2021	Millennium Management LLC	18,909	$0.13M	0.0%	-10.4%	0.190%
5/18/2021	Citadel Advisors LLC	18,421	$0.12M	0.0%	N/A	0.185%
5/13/2021	Wexford Capital LP	3,564,530	$23.70M	3.5%	+0.1%	35.781%
5/7/2021	BlackRock Inc.	23,559	$0.16M	0.0%	+20.9%	0.237%
4/27/2021	Cowen Prime Services LLC	622,750	$4.14M	1.6%	+8.3%	6.258%
2/12/2021	Elkhorn Partners Limited Partnership	14,290	$0.12M	0.1%	-9.0%	0.145%
2/11/2021	Samjo Capital LLC	550,000	$4.72M	4.0%	N/A	5.575%
2/10/2021	HighTower Advisors LLC	55,710	$0.48M	0.0%	+28.9%	0.565%
1/27/2021	Cowen Prime Services LLC	575,077	$4.93M	2.2%	+86.1%	5.829%
11/6/2020	BlackRock Inc.	18,333	$0.13M	0.0%	-28.1%	0.203%

Data available starting January 2016

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Today's Range

Now: $1.51

$1.48

$1.56

50 Day Range

MA: $1.56

$1.36

$1.84

52 Week Range

Now: $1.51

$1.36

$4.04

Volume

30,852 shs

Average Volume

7,835 shs

Market Capitalization

$15.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Nephros?: Nephros' top insider shareholders include:
Arthur H Amron (Director)
Robert R Jr Banks (CEO)
Learn More about top insider investors at Nephros.